CLDI
Price
$1.60
Change
+$0.03 (+1.91%)
Updated
Sep 5 closing price
Capitalization
8.4M
RYTM
Price
$102.12
Change
-$2.45 (-2.34%)
Updated
Sep 5 closing price
Capitalization
6.78B
66 days until earnings call
Interact to see
Advertisement

CLDI vs RYTM

Header iconCLDI vs RYTM Comparison
Open Charts CLDI vs RYTMBanner chart's image
Calidi Biotherapeutics
Price$1.60
Change+$0.03 (+1.91%)
Volume$245.04K
Capitalization8.4M
Rhythm Pharmaceuticals
Price$102.12
Change-$2.45 (-2.34%)
Volume$533.59K
Capitalization6.78B
CLDI vs RYTM Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. RYTM commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and RYTM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLDI: $1.60 vs. RYTM: $102.12)
Brand notoriety: CLDI and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 12% vs. RYTM: 70%
Market capitalization -- CLDI: $8.4M vs. RYTM: $6.78B
CLDI [@Biotechnology] is valued at $8.4M. RYTM’s [@Biotechnology] market capitalization is $6.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileRYTM’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, RYTM is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 3 TA indicator(s) are bullish while RYTM’s TA Score has 2 bullish TA indicator(s).

  • CLDI’s TA Score: 3 bullish, 4 bearish.
  • RYTM’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CLDI is a better buy in the short-term than RYTM.

Price Growth

CLDI (@Biotechnology) experienced а -3.03% price change this week, while RYTM (@Biotechnology) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

RYTM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($6.78B) has a higher market cap than CLDI($8.4M). RYTM YTD gains are higher at: 82.422 vs. CLDI (-88.406). CLDI has higher annual earnings (EBITDA): -17.92M vs. RYTM (-159.11M). RYTM has more cash in the bank: 291M vs. CLDI (5.28M). CLDI (4.01M) and RYTM (4.19M) have identical debt. RYTM has higher revenues than CLDI: RYTM (156M) vs CLDI (0).
CLDIRYTMCLDI / RYTM
Capitalization8.4M6.78B0%
EBITDA-17.92M-159.11M11%
Gain YTD-88.40682.422-107%
P/E RatioN/AN/A-
Revenue0156M-
Total Cash5.28M291M2%
Total Debt4.01M4.19M96%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDIRYTM
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 25 days ago
51%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPIDX69.99N/A
N/A
Invesco S&P 500 Index Y
ASRAX8.27N/A
N/A
Invesco Global Real Estate Income A
KNPAX117.89N/A
N/A
Kinetics Paradigm Adv A
GONIX14.70N/A
N/A
Gotham Neutral Institutional
FBCIX78.18N/A
N/A
American Funds Capital Income Bldr 529F2

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with ORYZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then ORYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
+1.91%
ORYZF - CLDI
37%
Loosely correlated
N/A
DYN - CLDI
33%
Poorly correlated
+7.40%
RYTM - CLDI
31%
Poorly correlated
-2.34%
DSGN - CLDI
30%
Poorly correlated
+5.56%
RXRX - CLDI
29%
Poorly correlated
+1.99%
More